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http://dx.doi.org/10.1016/j.stemcr.2016.10.007SUMMARYPrimordial germ cells (PGCs) are specified from epiblast cells in mice. Genes associated with naive pluripotency are repressed in the
transition from inner cell mass to epiblast cells, followed by upregulation after PGC specification. However, the molecular mechanisms
underlying the reactivation of pluripotency genes are poorly characterized. Here, we exploited the in vitro differentiation of epiblast-like
cells (EpiLCs) from embryonic stem cells (ESCs) to elucidate the molecular and epigenetic functions of PR domain-containing 14
(PRDM14). We found that Prdm14 overexpression in EpiLCs induced their conversion to ESC-like cells even in the absence of leukemia
inhibitory factor in adherent culture. This was impaired by the loss of Kruppel-like factor 2 and ten-eleven translocation (TET) proteins.
Furthermore, PRDM14 recruited OCT3/4 to the enhancer regions of naive pluripotency genes via TET-base excision repair-mediated
demethylation. Our results provide evidence that PRDM14 establishes a transcriptional network for naive pluripotency via active
DNA demethylation.INTRODUCTION
Cells in the human body can be broadly classified as two
major types, germline and somatic cells. The fusion of fully
differentiated germ cells (i.e., sperm and oocyte) produces a
totipotent zygote. Since all cells harbor the same genetic
code, differentiation depends on the epigenetic state of
each cell; germ cells reprogram epigenetic information
during their specification, development, and maturation
to acquire toti- or pluripotency. Germ cells inmice are spec-
ified from proximal epiblast cells that lack expression of
some subsets of pluripotency genes such as Nanog, Krup-
pel-like factor 2 (Klf2), and T cell leukemia/lymphoma 1
(Tcl1), which are regulated by the transcription factors B
lymphocyte-induced maturation protein 1 (BLIMP1), PR
domain-containing 14 (PRDM14), and transcription factor
AP-2 gamma (TFAP2C) (Nakaki et al., 2013; Ohinata et al.,
2005, 2009; Weber et al., 2010; Yabuta et al., 2006; Yamaji
et al., 2008). Specified PGCs reactivate pluripotency-asso-
ciated genes and can be used to derive embryonic germ
cells (EGCs) via stimulation with three cytokines, basic
fibroblast growth factor (bFGF), stem cell factor (SCF),
and leukemia inhibitory factor (LIF) (Matsui et al., 1992).
Migrating PGCs in the hindgut replace repressive DNA
methylation and H3K9 methylation marks with a repres-
sive H3K27 trimethylation mark in their genome during
migration (Seki et al., 2005, 2007). DNA demethylation
occurs as a two-step process: the first demethylation wave
occurs in a genome-wide manner during migration and a
second wave occurs in a locus-specificmanner, for example1072 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016 j ª 2016
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when PGCs arrive at the gonads (Seisenberger et al.,
2012). CpGmethylationmarks can be removed via replica-
tion-dependent and independent mechanisms (Wu and
Zhang, 2010). The former is regulated by inhibition of
DNA methyltransferase activity during de novo DNA
synthesis, whereas the latter (also known as active deme-
thylation) is triggered by oxidation of 5-methylcytosine
catalyzed by ten-eleven translocation (TET) proteins,
which is followed by base excision repair (BER) (Hackett
et al., 2012). PGCs use both active and passive demethyla-
tion to erase genome-wide methylation marks (Hajkova
et al., 2008; Kagiwada et al., 2013; Kawasaki et al., 2014;
Ohno et al., 2013; Popp et al., 2010). Global hypomethy-
lation is induced in the transition from metastable embry-
onic stem cells (ESCs) cultured with serum plus LIF to
ground-state ESCs cultured with 2i plus LIF, which is
similar to the first wave of DNA demethylation in migra-
tory PGCs (Ficz et al., 2013).
We have previously shown that PRDM14 is transiently
expressed in the inner cell mass (ICM) of blastocysts at
embryonic day 3.5 (E3.5) and reactivated in specifying
PGCs at approximately E6.25 (Yamaji et al., 2008).
Knockout (KO) studies have demonstrated that expression
of Prdm14 in the ICM is required for priming of the epiblast
cells for proper somatic differentiation (Payer et al., 2013),
and that expression of PGCs is critical for establishment of
the germline in mice (Yamaji et al., 2008). Furthermore, in-
duction of PRDM14 in epiblast-like cells (EpiLCs) induced
from ESCs is sufficient for PGC-like cell (PGCLC) inductionThe Author(s).
ns.org/licenses/by/4.0/).
in aggregate culture (Hayashi et al., 2011). KO and overex-
pression studies of Prdm14 suggest that PRDM14 is a critical
determinant for PGC specification in mice. However,
recent studies regarding human PGC induction from
pluripotent cells have clarified a difference in expression
of Prdm14 betweenmice and humans during the transition
frompluripotent cells to PGCs (Irie et al., 2015; Sasaki et al.,
2015). Interestingly, PRDM14 is consistently expressed at
moderate levels in pluripotent cells, i.e., primitive streak
cells, which are precursors of PGCs in human, and PGCs,
suggesting that PRDM14 is not a critical determinant for
PGC specification in humans.
Here, we exploited adherent culture of EpiLCs in which
Prdm14 expression is controlled by doxycycline (Dox) to
reveal the molecular and epigenetic function of PRDM14
during the transition from epiblast cells to PGCs in mice.
We showed that inducing Prdm14 expression in EpiLCs
in adherent culture promotes pluripotency and self-
renewal, resulting in conversion from EpiLCs to ESC-like
cells (ESCLCs).RESULTS
PRDM14 Overexpression Converts EpiLCs to ESC-like
Cells
Prdm14 is expressed inproximal epiblast cells at aroundE6.5
that constitute PGC precursors in mice. In three-dimen-
sional aggregate cultureofEpiLCs,PRDM14hasbeen shown
to be sufficient to induce PGCLCs (Nakaki et al., 2013). To
exclude the effect of cell-cell contact in three dimensions
and investigate the direct function of PRDM14 in PGC
development, we exploited adherent culture of EpiLCs, in
which Prdm14 expression was controlled by Dox treatment
(ROSA-Tet-off [Figures 1 and 5] andpiggyBac Tet-on [Figures
2, 3, 4, and 6]) (Figures 1A and 1B) (Hayashi et al., 2011).
ESCs were transferred onto fibronectin and stimulated
with bFGF and activin A in N2B27 medium containing 1%
KO serum replacement (KSR), and 2 days after EpiLC induc-
tion, Prdm14 expression was induced by removal of Dox
in Glasgow minimum essential medium containing 15%
KSR (GK15), which is the basic medium used for PGCLC
induction (Figures 1C and 1D) (Ohinata et al., 2009). The
morphology of EpiLCs expressing Prdm14 changed from
flattened to small, compact colonies, and the cells regained
alkaline phosphatase (AP) activity to a degree similar to that
of ESCs, which was associated with the reactivation of
pluripotency genes (Figures 1E and 1F). Interestingly, the
expression of early PGC markers in EpiLCs expressing
PRDM14 was comparable with that in ESCs, and we were
able to expand EpiLCs expressing PRDM14 at multiple pas-
sages, which clearly indicates that PRDM14 induction in
EpiLCs does not induce PGCLCs (Figure S1A). To evaluatethe self-renewal capacity and pluripotency of Prdm14-ex-
pressing EpiLCs, we assessed colony formation along with
AP activity in ESCs grownat lowdensityunder standard cul-
ture conditions (serumplus LIF). The number of AP-positive
colonies was higher for EpiLCs overexpressing PRDM14
than for control EpiLCs (Figure 1G). Interestingly, despite
the absence of LIF, we were able to expand PRDM14-ex-
pressing EpiLCs several times, and these cells retained
expression of pluripotency genes except for Klf4, which is
a direct target of LIF signaling (Figure S1B). Moreover, the
cells formed three germ layers in the subcutaneous region
of nude mice, indicating that PRDM14 expression confers
self-renewal capacity and pluripotency in EpiLCs indepen-
dent of LIF signaling (Figure 1H).
To determine the transcriptional dynamics in PRDM14-
expressing EpiLCs, we performed a microarray analysis us-
ing total RNA from ESCs, EpiLCs at day 2 (d2), EpiLCs +
PRDM14, and EpiLCs (d4). Unsupervised hierarchical clus-
tering revealed that the global gene expression profile of
EpiLCs + PRDM14 was more similar to that of ESCs than
that of EpiLCs (Figure 2A). Scatterplots of EpiLCs (d2) and
EpiLCs + PRDM14 showed that 669 genes, including those
associated with pluripotency, were upregulated, and 480
genes, including those encoding DNA methyltransferases
or associated with differentiation, were downregulated by
Prdm14 expression in EpiLCs (Figure 2B). Unsupervised
hierarchical clustering of genes up- or downregulated by
PRDM14 in EpiLCs formed four clusters (Figure 2C). Genes
in cluster 1 did not show a significant change in the transi-
tion from ESCs to EpiLCs, but were upregulated thereafter,
whereas cluster-2 genes showed downregulation from ESCs
to EpiLCs, followed by upregulation. Genes in cluster 3
showed relatively high expression from ESCs to EpiLCs
followed by downregulation, whereas those in cluster 4
showed upregulation from ESCs to EpiLCs before subse-
quent downregulation. According to gene ontology (GO)
functional annotations, stem cell maintenance (e.g., Tcl1,
Nanog, nuclear receptor subfamily [Nr]5a2, and estrogen-
related receptor b [Esrrb]), and DNA methylation (e.g.,
Dnmt3a/b) genes were enriched in clusters 2 and 4, respec-
tively (Figures 2C and 2D). PRDM14 overexpression in
epiblast stem cells (EpiSCs) partially activated pluripotency
genes without inducing their conversion to ESCs, even in
the presence of LIF (Gillich et al., 2012). To identify candi-
date genes regulated by PRDM14 that can account for the
difference between EpiLC and EpiSC conversion to ESCs,
we compared the top 1,000 probes that were differentially
upregulated by PRDM14 overexpression in EpiLCs and
EpiSCs according to published data (Gillich et al., 2012).
Critical pluripotency factors such as Tcl1, Nanog, Nr5a2,
transcription factor CP2-like 1 (Tfcp2l1), and T-box 3
(Tbx3) were upregulated by PRDM14 in EpiLCs but not
in EpiSCs (Figure 2E), suggesting that differences in theStem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016 1073
day 0
 ESCs
day 2
 EpiLCs d2
day 4
 EpiLCs d4
 EpiLCs
+ 
PRDM14
A B C
ESCs EpiLCs d2
EpiLCs d4 EpiLCs + PRDM14
D E
ESCs
EpiLCs d4
EpiLCs + PRDM14
F
G
bFGF, Activin A
+ 1% KSR/N2B27 
15% KSR/
GMEM 
+ PRDM14
H
0 
200 
400 
600 
800 
1000 
1200 
1400 
1600 
1800 
ES
Cs
 
Ep
iLC
s d
4 
Ep
iLC
s +
 P
RD
M1
4 
N
um
be
r o
f a
lk
al
in
e 
ph
os
ph
at
as
e
po
si
tiv
e 
co
lo
ni
es
 p
er
 1
00
00
 c
el
ls
P = 6.47×10-4
P = 4.04×10-4
SA rTA
rTA
rTA
rTA
hCMV*-1
CAG
Prdm14 IRES Venus
IRES Neo
OFF
loxP
rtTA
5’ TR 3’ TR
loxP
ROSA-Tet-off system
piggyBac Tet-on system
Tet-on
Tet-off
TetO
5’ TR 3’ TR
Prdm14
α-PRDM14
α-Tubulin
-Dox
-Dox
+Dox
+Dox
α-PRDM14
α-Tubulin
0 
5 
15 
20 
25 
30 
Prdm14 
ESCs 
EpiLCs d2 
EpiLCs d4 
EpiLCs + 
PRDM14 
R
el
at
iv
e 
m
R
N
A
 e
xp
re
ss
io
n 
10 
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
si
on
Endoderm
Mesoderm
Ectoderm
AFP
SMA
TUJ1
0 
0.5 
1 
1.5 
Oct3/4 Nanog Sox2 Klf2 Tcl1 Esrrb Nr5a2 
ESCs 
EpiLCs d2 
EpiLCs d4 
EpiLCs + PRDM14 
***
***
**
**
**
**
Figure 1. PRDM14 Induces the Transition of EpiLCs to ESCLCs
(A) Constructs of the ROSA-Tet-off system and piggyBac Tet-on system.
(B) Western blotting of PRDM14 and tubulin.
(C) Scheme of the transition of ESCs to EpiLCs and of EpiLCs to ESCLCs.
(D) qRT-PCR analysis of Prdm14 expression in ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14. Error bars indicate ±SD of a biological
triplicate.
(E) AP staining of ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14. Scale bar, 50 mm.
(F) qRT-PCR analysis of pluripotency genes in ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14. Error bars indicate ±SD of a biological
triplicate.
(G) Colony formation by ESCs, EpiLCs (d4), and EpiLCs + PRDM14 was assessed by AP staining over 3 days in the presence of serum + LIF.
Error bars indicate ±SD of biological triplicates. p Values were calculated with the Student’s t test. Scale bar, 200 mm.
(H) (Left) Teratoma formation by EpiLCs expressing Prdm14 cultured in the absence of LIF. (Right) Immunofluorescent staining of
a-fetoprotein (AFP), smooth muscle actin (SMA), and class III b-tubulin (TUJ1) in teratoma sections. Scale bar, 200 mm.
**p < 0.01, ***p < 0.001, Student’s t test.epigenetic landscape of pluripotency-associated genes
between EpiLCs and EpiSCs may be critical for their acti-
vation by PRDM14. In the case of genes downregulated
by PRDM14, epigenetic modifiers controlling DNA and
H3K9 methylation—including Dnmt3a, Dnmt3l, ubiqui-
tin-like PHD and RING finger domain-containing protein 1
(Uhrf1), helicase lymphoid-specific (Hells), and suppressor of1074 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016variegation 3–9 homolog 1 (Suv39h1)—were downregulated
by PRDM14 only in EpiLCs (Figure S2A), which may
be necessary for the establishment of an epigenetic
background that ensures the conversion from EpiLCs to
ESCLCs.
We used adherent EpiLC cultures to investigate the
function of PRDM14 while excluding the effects of
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Figure 2. Global Gene Expression Profiles in the Transition from EpiLCs to ESCLCs
(A) Unsupervised hierarchical cluster analysis of ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14.
(B) Scatter plots comparing the transcriptomes of EpiLCs + PRDM14 and EpiLCs (d2).
(C) Heatmap visualization of data obtained by unsupervised hierarchical cluster analysis of genes up- and downregulated by PRDM14 in
EpiLCs.
(D) GO term overrepresentation analysis using DAVID.
(E) Comparison of genes upregulated by PRDM14 in EpiLCs versus EpiSCs.
(F) Comparison of genes upregulated by PRDM14 and those most highly expressed in ESCs and d6 PGCLCs (Kurimoto et al., 2015).
(legend continued on next page)
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Figure 3. Klf2 Is Required for the PRDM14-Induced Reversion of EpiLCs to ESCLCs
(A) Immunoprecipitation of PRDM14 with KLF2 in ESCs.
(B) Western blot analysis of KLF2 expression in WT and Klf2 KO ESCs.
(C) qRT-PCR analysis of Prdm14 expression in WT and Klf2 KO ESCs. Error bars indicate ±SD of a biological triplicate.
(D) Colony formation by EpiLCs with or without Prdm14 induction induced from WT or Klf2 KO ESCs, as assessed by AP staining. Scale bar,
200 mm.
(E) Quantification of colony formation shown in (D). Error bars indicate ±SD of biological triplicates. p Values were calculated with
Student’s t test.
(F) Scatter plot shows relative Ct values of pluripotency-associated genes (red dots) and differentiation markers (blue dots) determined
by qRT-PCR. The x axis indicates relative Ct values of each gene (EpiLCs + PRDM14  EpiLCs [d2]) in WT, and the y axis indicates relative
Ct values of each gene (EpiLCs + PRDM14  EpiLCs [d2]) in Klf2 KO.three-dimensional cell-cell contact. EpiLCs expressing
PRDM14 could be expanded for long time periods,
implying that EpiLCs were not induced to become PGCLCs
under our culture conditions. In contrast, forced expres-
sion of PRDM14 in aggregate EpiLC cultures induced
PGCLCs but not ESCLCs (Nakaki et al., 2013). Germ cell
specification consists of two major events: the acquisition
of potential pluripotency (by reactivation of genes such
asNanog, Klf2, and Tcl1) and of germ cell character (by acti-
vation of Blimp1, Nanos3, and dead-end protein homology 1)
(Kurimoto et al., 2008; Yamaji et al., 2008). The difference(G) qRT-PCR analysis of pluripotency and germ cell-related genes in
aggregate cultures. Error bars indicate ±SD of a biological triplicate.
(H) Comparison of the expression of PGC markers, Blimp1 (mVENUS) an
EpiLCs with PRDM14. Scale bar, 200 mm.
1076 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016in cell fate between PRDM14-expressing EpiLCs grown
as adherent or aggregate cultures suggests that acquisition
of pluripotency is directly controlled by PRDM14, while
three-dimensional cell-cell interactions between EpiLCs
are required for the induction of germ cell characteristics,
including the activation of germline-specific genes. A
recent analysis of global gene expression in the differentia-
tion of ESCs to EpiLCs and of EpiLCs to PGCLCs identified
genes that were enriched in ESCs, EpiLCs, and d2 and d6
PGCLCs (Kurimoto et al., 2015). We compared the charac-
teristics of EpiLCs expressing PRDM14 grown under ourEpiLCs, and EpiLCs expressing PRDM14 and grown as adherent or
*p < 0.05, **p < 0.01, Student’s t test.
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Figure 4. Reversion from Primed to Naive Pluripotency Induced by PRDM14 via the TET-BER Pathway
(A) qRT-PCR analysis of Prdm14 and pluripotency genes in ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14 in WT and Tet1/2 KD
backgrounds. Error bars indicate ±SD of a biological triplicate. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test.
(B) Colony formation by EpiLCs with or without Prdm14 induction induced fromWT and Tet1/2 KD ESCs, as determined by AP staining. Scale
bar, 200 mm. Error bars indicate ±SD of biological triplicates. p Values were calculated with Student’s t test.
(C) Glucosylation of genomic DNA followed by methylation-sensitive (GlucMS)-qPCR analysis showing the percentage of 5mC and 5hmC
marks in or near PRDM14 binding regions of the Nanog and Tcl1 enhancers in ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14 in WT and
Tet1/2 KD backgrounds. Error bars indicate ±SD of a biological triplicate.
(D) qRT-PCR analysis of Prdm14, pluripotency genes, and Fgf5 in ESCs, EpiLCs (d2), EpiLCs (d4), and EpiLCs + PRDM14 treated with DMSO
(control), 3-aminobenzamide (3AB), and CRT 004876 (CRT). Error bars indicate ±SD of a biological triplicate. *p < 0.05, **p < 0.01,
***p < 0.001, Student’s t test.
(E) Colony formation by EpiLCs + PRDM14 treated with DMSO, 3AB, and CRT as assessed by AP staining. Error bars indicate ±SD of a
biological triplicate. p Values were calculated with Student’s t test. Scale bar, 200 mm.culture conditions with ESC highest genes, d6 PGCLCs,
and EpiLC highest genes in a Venn diagram. The majority
of transcription factors critical for ESC pluripotency amongESC highest genes were upregulated by PRDM14 in
adherent EpiLC cultures, while genes most highly ex-
pressed in d6 PGCLCs were generally not upregulated byStem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016 1077
PRDM14 in these cultures including Blimp1 (Prdm1), a crit-
ical determinant of germ cell specification (Ohinata et al.,
2005) (Figures 2F and 2G). These findings led us to specu-
late that a combination of Prdm14 induction and three-
dimensional cell-cell contact is necessary for the induction
of Blimp1 expression in EpiLCs. To clarify the response
of EpiLCs to PRDM14 induction in aggregate culture
and adherent culture, we established PRDM14-inducible
ESCs carrying two reporters, Blimp1-mVENUS (BV) and
stella-eCFP (SC) (BVSC), and monitored the fluorescence
of mVENUS and eCFP in different culture conditions
(Hayashi et al., 2011). At 2 days after PRDM14 induction
in EpiLCs at aggregate culture, the aggregates showed
both BV and SC expression (Figure 2H), which provides
evidence of PGCLC induction, as shown in a previous
study (Nakaki et al., 2013). By contrast, adherent-cultured
EpiLCs expressing PRDM14 showed no BV expression
and weak SC expression, which is consistent with the
expression profile in ESCs (Hayashi et al., 2011). Blimp1
is upregulated by the mesoderm marker gene T (Brachyury)
(Aramaki et al., 2013).We therefore compared Texpression
levels in adherent and aggregate EpiLC cultures. Interest-
ingly, T was only upregulated in EpiLC aggregate cultures
both with and without Prdm14 induction (Figure 2G),
suggesting that three-dimensional cell-cell interactions
are required for T expression, which induces PGCs along
with PRDM14. A comparison of genes downregulated by
PRDM14 in adherent EpiLC cultures with EpiLC highest
genes showed that many EpiLC highest genes including
Otx2 and Foxd3 (Buecker et al., 2014; Respuela et al.,
2016), which are known to important for the transition
from naive to primed pluripotency, were repressed by
PRDM14, indicating that PRDM14 suppresses epiblast
characteristics (Figure S2B).
Klf2 Is Required for the Acquisition of Pluripotency by
PRDM14
Adherent culture of EpiLCswith PRDM14 is a powerful tool
to uncover the molecular and epigenetic mechanisms for
potential re-establishment of pluripotency by PRDM14,
because this system induces the conversion from EpiLCs
to ESCLCs at high efficiency and uniformly. We first
focused on the function of KLF2, which is activated soon
after induction of PRDM14 in EpiLCs in adherent culture.
KLF2 has been shown to act synergistically with PRDM14
in the reversion of EpiSCs to ESCs (Gillich et al., 2012);
the interaction between the two proteins in ESCs was
confirmed by immunoprecipitation (IP) (Figure 3A). To
clarify the role of Klf2 in the PRDM14-associated acquisi-
tion of pluripotency, we generated Klf2 KO ESCs harboring
a Dox-inducible Prdm14 expression cassette using the
clustered regularly interspaced short palindromic repeats
(CRISPR)/Cas9 system (Figures 3B and 3C). Interestingly,1078 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016we did not observe AP-positive colonies in Klf2-null EpiLCs
expressing PRDM14, which demonstrated that Klf2 is
essential for the PRDM14-induced conversion of EpiLCs
to ESCLCs (Figure 3D and 3E). To clarify the cause of the
loss of AP activity in EpiLCs + PRDM14 in Klf2 KO, we
compared the repression of differentiation markers and
activation of pluripotency-associated markers by PRDM14
in wild-type (WT) and Klf2 KO using qRT-PCR analysis.
We plotted the relative Ct values of qRT-PCR data (EpiLCs +
PRDM14  EpiLCs [d2]) for WT (y axis) and Klf2 KO
(x axis). Consistent impairment of activation of pluripo-
tent-associated genes by PRDM14 was observed, whereas
the repression of differentiation markers by PRDM14 was
relatively maintained in Klf2 KO EpiLCs (Figure 3F). These
results indicate that PRDM14 cooperates with KLF2 to
convert EpiLCs to ESCLCs through the activation of plurip-
otency-associated genes.
PRDM14-Induced Acquisition of Pluripotency Occurs
via TET-Dependent Active Demethylation
We previously showed that PRDM14 promotes active de-
methylation of pluripotency genes in ESCs via the TET-
BER pathway (Okashita et al., 2014). To assess the role of
the TET-BER pathway in PRDM14-induced acquisition of
pluripotency, we established a Tet1/Tet2 knockdown (KD)
ESC linewith aDox-inducible Prdm14 cassette (Figure S3A).
Tet1/Tet2 KD prevented the reactivation of Nanog, Klf2,
Tcl1, and Esrrb but not of Sox2 and also prevented AP-pos-
itive colony formation by PRDM14 under ESC culture con-
ditions (Figures 4A and 4B), while the repression ofDnmt3b
and differentiationmarkers by PRDM14 occurred normally
inTet1/Tet2KDEpiLCs (Figure S3B). CpGmethylation level
at PRDM14 binding regions of Nanog and Tcl1 in ESCs sub-
stantially increased in the transition from ESCs to EpiLCs;
these marks were rapidly removed by Prdm14 induction
(Figure 4C). In contrast, the removal of 5-methylcytosine
(5mC) by PRDM14 at Nanog and Tcl1 loci was impaired
by Tet1/Tet2 KD. Furthermore, treatment of EpiLCs ex-
pressing PRDM14 with pharmacological inhibitors of the
BER components DNA endonuclease apurinic/apyrimi-
dinic endonuclease (3-aminobenzamide) and poly(ADP-
ribose) polymerase (CRT 004876) abrogated the reversion
of EpiLCs to ESCLCs, similar to the Tet1/Tet2 KD pheno-
type (Figures 4D and 4E). To investigate the role of TET
proteins in global gene expression profiles regulated by
PRDM14 in EpiLCs, we compared genes that were up- or
downregulated by PRDM14 inWTandTet1/Tet2KDEpiLCs
by microarray analysis. Genes that were up- or downre-
gulated by PRDM14 in WT EpiLCs showed corresponding
up- and downregulation in Tet1/Tet2 KD EpiLCs (Fig-
ure S4A). These genes were of four types: ESC-, PGC-,
or EpiLC-enriched, or epigenetic modifiers. We examined
the effect of Tet1/Tet2 KD on the transcriptional regulation
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Figure 5. PRDM14 Increases OCT3/4 Recruitment to Klf2 via the TET-BER Pathway
(A) Schematic representation of ChIP data for PRDM14 and OCT3/4 at the Klf2 locus in ESCs (Hall et al., 2009; Ma et al., 2011) and PRDM14
and OCT3/4 recognition motifs at two enhancers.
(B) ChIP-qPCR analysis of PRDM14 (a-FLAG) and OCT3/4 at the Klf2 locus in ESCs, EpiLCs (d2), and EpiLCs + PRDM14. Fold enrichment was
calculated by comparing pre-immune immunoglobulin G (IgG) control (red dotted line) with each antibody. Error bars indicate ±SD of a
technical duplicate.
(C) GlucMS-qPCR analysis showing the percentage of 5mC and 5hmCmarks at two Klf2 enhancers in ESCs, EpiLCs (d2), and EpiLCs + PRDM14.
Error bars indicate ±SD of a technical duplicate.
(D) ChIP-qPCR analysis of PRDM14 (a-FLAG) and OCT3/4 at the Klf2 locus every 6 hr after Prdm14 induction. Error bars indicate ±SD of a
technical duplicate.
(E) Western blot (WB) analysis of FLAG, OCT3/4, TET1, and TET2 levels following immunoprecipitation (IP) of EpiLCs + PRDM14 precipitated
with an anti-FLAG antibody.
(legend continued on next page)
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of these genes by PRDM14 in EpiLCs (Figure S4B). The
expression of PGC- and EpiLC-enriched genes and epige-
netic modifiers was unaltered by PRDM14 in Tet1/Tet2
KD EpiLCs. In contrast, activation of ESC-enriched genes
by PRDM14 was impaired in Tet1/Tet2 KD EpiLCs. We
observed, however, that ESC-enriched genes tended to be
upregulated by PRDM14 even in Tet1/Tet2 KD EpiLCs,
suggesting that TET proteins cooperate with an unknown
pathway regulated by PRDM14 to activate ESC-enriched
genes in EpiLCs (Figure S4B).
PRDM14 Enhances OCT3/4 Binding toKlf2 Enhancers
via the TET-BER Pathway
Because Klf2 activation is critical for acquisition of plu-
ripotency by PRDM14, we investigated the molecular and
epigenetic mechanisms of Klf2 activation by PRDM14.
Both PRDM14 and OCT3/4 bind to proximal and distal en-
hancers of the Klf2 locus in ESCs (Figure 5A) (Hall et al.,
2009; Ma et al., 2011). We therefore evaluated the binding
of PRDM14 and OCT3/4 to the Klf2 locus in the transition
from ESCs to EpiLCs and dedifferentiation of EpiLCs to
ESCLCs by chromatin IP (ChIP)-qPCR. Since ChIP-grade
anti-PRDM14 antibody was unavailable, we detected the
binding of exogenous FLAG-PRDM14 in EpiLCs using an
anti-FLAG antibody (Figure 5B). After Prdm14 expression
was induced in EpiLCs, two distinct peaks appeared at the
proximal and distal enhancers of Klf2 (Figure 5B). Under
our culture conditions, OCT3/4 was present only at distal
enhancers of Klf2, and this peak disappeared in the
transition from ESCs to EpiLCs (Figure 5B). Interestingly,
induction of Prdm14 expression enhanced the binding of
OCT3/4 at both proximal and distal enhancers of Klf2 in
EpiLCs.
We next measured 5mC and 5hmC levels at two en-
hancers of Klf2 in ESCs, EpiLCs, and EpiLCs + PRDM14.
In ESCs, 5mC was detected only at proximal enhancers
of Klf2, which was correlated with absence of OCT3/4 at
the proximal enhancer (Figures 5B and 5C). At the distal
enhancer of Klf2, 5mC level was transiently upregulated
during the differentiation of ESCs to EpiLCs; this was
followed by a downregulation induced by PRDM14. In
contrast, the 5hmC level remained constant. To determine
the temporal hierarchy of events (PRDM14 and OCT3/4
binding, 5mC removal, and activation of Klf2 expression),
we analyzed Prdm14 andKlf2 expression aswell as PRDM14(F) GlucMS-qPCR analysis of the percentage of 5mC and 5hmC mark
indicate ±SD of a technical duplicate.
(G) GlucMS-qPCR showing the percentage of 5mC and 5hmC marks at th
3-aminobenzamide (3AB), or CRT 004876 (CRT). Error bars indicate ±
(H) ChIP-qPCR analysis of PRDM14 (a- FLAG) and OCT3/4 at the Klf
enrichment was calculated by comparing pre-immune IgG control (
technical duplicate.
1080 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016and OCT3/4 binding, and 5mC and 5hmC distribution at
the two Klf2 enhancers every 6 hr after Prdm14 induction
in EpiLCs. Prdm14 expression was detected starting 18 hr
after induction; this was followed by increased PRDM14
binding at the two enhancers at 24 hr (Figures 5D, S5A,
and S5B). In contrast, OCT3/4 binding at these sites first
appeared 42 hr after Prdm14 induction (Figures 5D and
S5B). PRDM14 was found to interact with TET1 and TET2
but not with OCT3/4 in EpiLCs (Figure 5E), suggesting
that PRDM14 indirectly enhances OCT3/4 recruitment to
these enhancers. Interestingly, the level of 5mC rapidly
reduced while that of 5hmC increased after PRDM14
recruitment to these enhancers (Figures 5F and S5C). To
determine whether active demethylation by PRDM14 is
required for OCT3/4 binding, we examined the effects of
BER inhibitor (BERi) on 5mC removal from and OCT3/4
recruitment to these enhancers. BERi treatment completely
disrupted the rapid removal of 5mC by PRDM14 at both
Klf2 enhancers in EpiLCs (Figures 5G and S5D). Under
these conditions, OCT3/4 recruitment was abrogated
although PRDM14 enrichment was unaltered (Figures 5H
and S5E). Taken together, these data indicate that
PRDM14 activates Klf2 expression via active demethyla-
tion-mediated recruitment of OCT3/4 to the enhancers
(Figure S5F).
To identify the genomic regions at which PRDM14
enhances OCT3/4 recruitment, we performed ChIP for
OCT3/4 and PRDM14 (a-FLAG) followed by deep
sequencing (ChIP-seq) in ESCs, EpiLCs, and EpiLCs
expressing PRDM14, and identified 18,093, 8,136, and
13,882 OCT3/4 peaks, respectively, using the MACS2 call-
peak (Feng et al., 2012). Next, to investigate the effects of
PRDM14 on OCT3/4 binding, we compared the enrich-
ment of OCT3/4 peaks among ESCs, EpiLCs, and EpiLCs
expressing PRDM14 by using the MACS2 bdgdiff module
(Feng et al., 2012). Over half of the OCT3/4 binding in
ESCs was reduced and only 312 peaks increased in the tran-
sition of ESCs to EpiLCs (Figure 6A); 2 days after PRDM14
induction, 2,542 OCT3/4 binding peaks increased or had
appeared, and those corresponding to 1,559 genes colocal-
ized with PRDM14 binding peaks (Figure 6B). Approxi-
mately 6.3% (98 of 1,559) of genes in which OCT3/4
binding was enhanced by PRDM14 were upregulated by
PRDM14, whereas approximately 2.8% (43 of 1,559) of
genes in which OCT3/4 binding was upregulated bys at the Klf2 locus every 6 hr after Prdm14 induction. Error bars
e Klf2 locus in EpiLCs + PRDM14 treated with DMSO(DMSO; control),
SD of a technical duplicate.
2 locus in EpiLCs + PRDM14 treated with DMSO, 3AB, or CRT. Fold
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Figure 6. Enhancement of OCT3/4 Binding by PRDM14 during Reversion from Primed to Naive Pluripotency
(A) Comparison of OCT3/4 binding peaks between ESCs and EpiLCs (d2), EpiLCs (d2) and EpiLCs + PRDM14, and EpiLCs + PRDM14 and ESCs.
Numbers in gray rectangles indicate peaks common to both cell types in each pair. Numbers in blue, red, and green rectangles indicate
peaks specific to ESCs, EpiLCs (d2), and EpiLCs + PRDM14, respectively.
(B) Genes downregulated by PRDM14 during the transition from EpiLCs to ESCLCs (red circles). Genes associated with PRDM14 and OCT3/4
binding that were enhanced during the transition of EpiLCs to ESCs are indicated by navy circles; genes upregulated by PRDM14 in EpiLCs
are shown by yellow circles.
(C) GO annotation of genes upregulated by PRDM14 in which OCT3/4 binding increased with PRDM14 binding (from EpiLCs to EpiLCs +
PRDM14).
(D) ChIP-seq tracks of OCT3/4 and PRDM14 in ESCs, EpiLCs (d2), and EpiLCs + PRDM14. Intensity values of microarray data are shown on the
right side. Red bar indicates the position of the primers for ChIP-qPCR and GlucMS-qPCR.
(E) ChIP-qPCR analysis of OCT3/4 and PRDM14 expression in ESCs, EpiLCs (d2), and EpiLCs + PRDM14. Fold enrichment indicates values of
each IgG relative to input values using the same amount of DNA as template. Error bars indicate ±SD of a technical duplicate.
(F) GlucMS-qPCR analysis of the percentage of 5mC and 5hmC marks at pluripotency genes. Error bars indicate ±SD of a technical duplicate.PRDM14 were downregulated by Prdm14 induction in
EpiLCs (Figure 6B). An overrepresentation analysis using
DAVID (Huang et al., 2007) revealed that GO terms relatedto stem cell maintenance, including Tcl1, Nr5a2, and
Tfcp2l1, were enriched among the upregulated genes
(Figures 6C and 6D). Consistent with ChIP-seq data, theStem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016 1081
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Figure 7. Working Model of the Role of
PRDM14 in the Conversion of EpiLCs to
ESCLCs and PGC Specificationenrichment of OCT3/4 binding at five of the genes
decreased during differentiation of ESC to EpiLC, with
a consequent increase in OCT3/4 binding peaks by
PRDM14 binding-associated induction (Figure 6E). To
determine whether PRDM14-mediated DNA demethy-
lation modulates the recruitment of OCT3/4 to the five
genes, we measured 5mC and 5hmC levels at the bind-
ing regions of OCT3/4 and PRDM14 by glucosylation
of genomic DNA followed by methylation-sensitive
(GlucMS)-qPCR (Figure 6F). 5mC levels were elevated at
all genes analyzed during ESC-to-EpiLC differentiation,
whereas at three of the five genes the levels decreased after
PRDM14 induction in EpiLCs. These findings indicate
that PRDM14 acts via DNA demethylation-dependent
and -independent mechanisms to recruit OCT3/4.DISCUSSION
This study provides evidence that PRDM14 confers plurip-
otency and self-renewal capacity to EpiLCs by reactivating
pluripotency genes via TET-BER-mediated active demethy-
lation (Figure 7). Nascent PGCs reactivate pluripotent-asso-
ciated genes during specification from epiblast cells. Our
data suggest that the activation of PRDM14 in epiblast is
a key event for reactivation of pluripotent-associated genes
and the acquisition of potential pluripotency. Our data
demonstrate that EpiLC culture conditions (i.e., adherent
versus aggregate) determine the expression of two key
genes for PGC specification, T and Blimp1 (Ohinata et al.,
2005) (Figures 2G and 2H). Moreover, adherent EpiLC
cultures with Prdm14 induction resulted in the conversion
of EpiLCs to ESCLCs, whereas three-dimensional aggregate
cultures induced PGCLCs (Nakaki et al., 2013). It has been
shown that the WNT3-b-catenin axis induces T expression
in epiblast culture in aggregate culture of EpiLCs (Aramaki
et al., 2013). Therefore, we consider that aggregate culture
of EpiLCs enhance WNT3-b-catenin signaling to activate
T expression. Further experiments are needed to clarify1082 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016whether the combination of PRDM14 with BLIMP1 or
T can induce PGCLCs from EpiLCs in adherent culture.
Tet1/Tet2 KD and BERi treatment impaired the reacti-
vation of pluripotency genes by PRDM14, reducing the
conversion efficiency of EpiLCs to ESCLCs. However, the
reactivation of pluripotency genes by PRDM14 was
partially inhibited by Tet1/Tet2 KD and BERi treatment,
implying that PRDM14 acts via a TET-BER-indepen-
dent mechanism in this process. Furthermore, PRDM14-
induced activation of PGC-enriched genes including
Tfap2c, developmental pluripotency-associated 3 (Dppa3),
and reproductive homeobox 6/9 (Rhox6/9) was normal
in Tet1/Tet2 KD EpiLCs. These data are consistent with
the phenotype of Tet1/Tet2 double KO (DKO) PGCs, and
demonstrate normal PGC specification and development
(Yamaguchi et al., 2012). Further studies examining the
developmental potential of EGCs derived from Tet1/Tet2
DKO PGCs are needed to clarify the function of TET1/
TET2 in the acquisition of pluripotency by PGCs in vivo.
The concordance between ChIP-seq and microarray
data provided evidence that PRDM14 recruits OCT3/4 to
enhancer regions of pluripotency genes, leading to their
transcription during the conversion from EpiLCs to
ESCLCs. The 5mC marks at Nr5a2, Tfcp2l1, and Tfap2c
enhancers were removed by PRDM14 in EpiLCs, while
5mC at replication timing regulatory factor 1 (Rif1) and
spalt-like transcription factor 4 (Sall4) enhancers were un-
changed. Interestingly, the reactivation of Rif1 and Sall4
by PRDM14 was impaired in Tet1/Tet2 double KD EpiLCs
(Figure S4B). These results suggest that TET proteins are
involved in the reactivation of Rif1 and Sall4 by PRDM14
via DNA demethylation-independent mechanisms. In sup-
port of this possibility, TET proteins were required for the
recruitment of O-linked N-acetylglucosamine (O-GlcNAc)
transferase to target chromatin, which leads to its activa-
tion via O-GlucNAcylation of histone H2B (Chen et al.,
2013; Vella et al., 2013).
Recently, various groups have independently succeeded
in inducing human PGCLCs from human pluripotent
stem cells (PSCs) (Irie et al., 2015; Sasaki et al., 2015;
Sugawa et al., 2015). For instance, human PGCLCs were
more robustly induced from mesoderm-like cells (iMeLCs)
and human ESCs cultured in medium containing four
inhibitors, called ‘‘4i’’ medium; they expressed somemeso-
dermmarkers. Althoughmost naive pluripotency genes are
repressed in the transition from ESCs to EpiLCs in mice,
most genes including KLF2, TCL1A, ESRRB, TFCP2L1,
and nuclear receptor subfamily 0 B1 (NR0B1) showed
low expression in human ESCs/induced PSCs (iPSCs).
Although expression of Prdm14 is closely associated with
naive pluripotency in mice, primed human ESCs/iPSCs,
primitive streak-like cells, iMeLCs, and 4i ESCs consistently
express PRDM14 at moderate levels. Therefore, the specific
upregulation of Prdm14 observed during the transition
from pluripotent cells to PGCs in mice does not occur in
human PGC specification. The present study has clearly
demonstrated that PRDM14 governs the transcriptional
network for pluripotency in the absence of BLIMP1 in
mice. In contrast to early mouse embryos, epiblast cells in
human early embryos need to maintain pluripotency for
longer than 10 days until the emergence of PGCs. Further-
more, primitive streak-like cells, which have a high capac-
ity for PGC specification, retain pluripotency markers
including NANOG and PRDM14 (Irie et al., 2015; Sasaki
et al., 2015). On this basis, we hypothesize that continuous
expression of PRDM14 is essential for the long-term main-
tenance of pluripotent cells to give rise to PGCs in humans.
In contrast to our hypothesis, it has also been shown that
PRDM14 KD ESCs are competent for PGCLC induction,
which led to the conclusion that PRDM14 is not neces-
sary for PGC induction in humans (Sugawa et al., 2015).
However, another group has clearly shown that PRDM14
KD induces human ESC differentiation (Chia et al.,
2010), implying that the KD efficiency in the study of
Sugawa et al. (2015) was quite low and that conclusions
cannot be drawn regarding the role of PRDM14 in human
PGC development. Therefore, additional KO studies are
needed to clarify the molecular and epigenetic functions
of PRDM14 in the human germline.
The conversion of EpiLCs to ESCLCs is similar to the late
stage of somatic cell reprogramming, since activation of
pluripotency genes by PRDM14 is associated with DNA
demethylation of their promoters. Given these findings,
we consider that PRDM14-dependent activedemethylation
of pluripotency genes is required for progression of the late
stage of somatic cell reprogramming. This is supported by
the fact that Prdm14 KO fibroblasts failed to be converted
to iPSCs in the absence of Nanog and Sox2 reactivation un-
der standard ESC culture conditions (Payer et al., 2013).
Furthermore, epigenetic errors result in partially reprog-
rammed iPSCs and low-grade iPSCs (Stadtfeld et al., 2010;
Tran et al., 2015). Our findings provide a framework forunderstanding not only physiological but also artificial
(e.g., iPSC derivation) and pathological (e.g., the appear-
ance of cancer stem cells) reprogramming.EXPERIMENTAL PROCEDURES
Cell Culture
E14tg2a ESCs were cultured in Glasgow minimum essential me-
dium (Wako) containing 10% fetal calf serum (Invitrogen), 1 mM
glutamine (Wako), nonessential amino acid (Wako), and 0.1 mM
2-mercaptoethanol (Wako). The culture was supplemented with
LIF (Wako) in the absence of feeder cells.
Teratoma Formation and Histological Analysis
Approximately 5 3 106 EpiLCs expressing PRDM14, cultured
without LIF, were injected subcutaneously into both the flanks
of female nude mice. After 30 days, the tumors were excised,
embedded in paraffin, and sectioned into 4-mm-thick slices. H&E
staining was done according to the standard protocol. Markers for
the three germ layers were monitored with immunofluorescence
with antibodies: a-AFP (Proteintech; 14550-1-AP), a-SMA (Abcam;
ab5694), and a-b-tubulin (Cell Signaling; catalog no. 2146). These
experiments were conducted according to the Kwansei Gakuin
University Regulation for Animal experimentation.
Generation of Prdm14-Inducible ESCs by ROSA-Tet-
Off and piggyBac Tet-On
For the ROSA-Tet-off system, EBRTcH3 cells were transfected with
pZhc-Prdm14 and pCAGGS-Cre (Masui et al., 2005). For the Tet-on
system, E14tg2a ESCs and BVSC ESCs (Hayashi et al., 2011)
were transfected with PB-TET-FLAG-Prdm14-IRES-Neo, PB-CA-
rtTA Adv, pCAG-Pbase, and pGG131 (pCAG-DsRed-IRES-Hygro).
The cells were grown in selective medium containing 1.5 mg/mL
puromycin (Sigma-Aldrich) and 200 mg/mL hygromycin B
(Wako) for 7 days (Okashita et al., 2014). Colonies were picked
and analyzed by qRT-PCR and western blotting to determine
PRDM14 expression levels, with and without doxycycline.
RNAi
Tet1 and Tet2 small hairpin RNAs (shRNAs) were generated from
pLKO.1-puro (Addgene; 8453) or pLKO.1-blast (Addgene; 26655).
The Tet1 and Tet2 shRNAs were adapted for pLKO.1 plasmids.
The RNAi target sequences are presented in Table S1. pLKO.1 len-
tiviruses were constructed according to the Addgene pLKO.1 pro-
tocol (http://www.addgene.org/). pLKO.1 plasmids were co-trans-
fected with pCMV-VSV-G (Addgene; 8454) and pCMV-dR8.2
dvpr (Addgene; 8455) into HEK293T cells. Lentivirus-containing
supernatants were centrifuge-filtered through a 0.45-mm filter.
Clarified supernatants were combined using the Lenti-X Concen-
trator (Clontech) according to the manufacturer’s protocol. The
mixture was centrifuged, after which the supernatant was carefully
removed and the pellet resuspended in DMEM.
For lentivirus transduction, subconfluent iP14 ESCs were
incubated with lentivirus-containing DMEM supplemented with
8 mg/mL polybrene (Sigma-Aldrich) for 24 hr. After changing
the spent medium with fresh medium, cells were selected withStem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016 1083
2 mg/mL puromycin (Sigma-Aldrich) or 20 mg/mL blasticidin S hy-
drochloride (Calbiochem). Knockdown efficiency was analyzed by
qRT-PCR and western blotting.
Generation of Klf2-Knockout ESCs Using a CRISPR/
Cas9 System
Klf2 guide RNA was adapted for and generated from the pX330-
U6-Chimeric_BB-CBh-hSpCas9 plasmid (Addgene; 42230). The
Klf2 guide RNA sequences are presented in Table S1. The estab-
lished plasmid was co-transfected with pCAG-IRES-Puro into the
induced PRDM14 ESCs, and the transfected cells were selected
with 2 mg/mL puromycin. KLF2 expression was analyzed by west-
ern blot.
Induction of EpiLCs
ESCs were cultured in N2B27 basal medium containing 3 mM
CHIR99021 (Wako), 0.4 mM PD0325901 (Wako), and LIF in a dish
coated with 0.01% poly-L-ornithine (Millipore) and 10 ng/mL
laminin (BD Biosciences). Induction of EpiLCs was performed as
described previously (Hayashi et al., 2011). EpiLCs were induced
from ESCs in N2B27 basal medium containing 20 ng/mL activin
A (Peprotech), 12 ng/mL bFGF (Invitrogen), and 0.1–1% KSR for
2 days on a dish coatedwith 16.7 mg/mLhumanplasmafibronectin
(Millipore). Twodays after EpiLC induction, the cellswere collected
and replated (0.5–1.03 105) with or without doxycycline in GK15
medium on a dish coated with 16.7 mg/mL human plasma fibro-
nectin. For the colony formation assay for AP-positive cells, ESCs,
EpiLCs, andEpiLCs inducedwithorwithout PRDM14were dissoci-
ated by TrypLE Select (Invitrogen). Cells (1.0 3 104) were cultured
under standard ESC culture conditions. After culture for 3 days,
the cells were stained for AP activity. The aggregate culture of
EpiLCs was performed as previously reported (Nakaki et al.,
2013). In brief, after 36 hr of EpiLC induction the cells were
collected, and 2,000 cells per well were transferred to a low-cell
binding 96-well plate (NUNC). The cells were grown for 2 days in
GK15 medium with or without 1.5 mg/mL doxycycline.
qRT-PCR
Total RNA was extracted using TRIzol (Invitrogen). The ReverTra
Ace qPCR RT kit (Toyobo) was used for cDNA synthesis according
to the manufacturer’s instructions. Subsequently, cDNA was used
as a template for qPCR with the Thunderbird SYBR qPCR Mix
(Toyobo) and gene-specific primers (Table S1) on a LightCycler
96 system (Roche).
Western Blot and Immunoprecipitation Analysis
Cells were lysed by boiling in SDS sample buffer (Wako). The total
proteins from lysed cells were denatured by 2-mercaptoethanol
and were then applied to polyacrylamide-SDS gels. The proteins
were separated on polyacrylamide-SDS gels, blotted on polyvinyli-
dene fluoride membrane, and probed using the following pri-
mary antibodies: a-PRDM14 (R &D Systems; MAB8097), a-tubulin
(Sigma; T5168), a-histone H3 (Abcam; ab1791), a-FLAG (Sigma;
F1804), a-KLF2 (Millipore; 09–820), a-TET1 (Millipore; 09–872),
a-TET2 (Santa Cruz Biotechnology; sc-136926), and a-OCT3/4
(Santa Cruz; sc-8628). Following the primary antibody reaction,
the membrane was incubated with secondary horseradish peroxi-1084 Stem Cell Reports j Vol. 7 j 1072–1086 j December 13, 2016dase-coupled antibodies. Detection was achieved using the Lumi-
nata Forte Western HRP Substrate (Millipore). For immunoprecip-
itation analysis, extracts containing a protease inhibitor cocktail
(Roche) were incubated with anti-PRDM14 antibody or anti-
OCT3/4 antibody for 2 hr at 4C, and captured with protein A
beads. Protein complexes were washed with wash buffer (50 mM
Tris-HCl [pH 8.0], 150mMNaCl, 1%NP-40), and eluted by boiling
with SDS sample buffer.
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